Wang Y - Search Results

1

GATA2 negatively regulates PTEN by preventing nuclear translocation of androgen receptor and by androgen-independent suppression of PTEN transcription in breast cancer.

Wang Y, He X, Ngeow J, Eng C. Wang Y, et al. Hum Mol Genet. 2012 Feb 1;21(3):569-76. doi: 10.1093/hmg/ddr491. Epub 2011 Oct 21. Hum Mol Genet. 2012. PMID: 22021428

2

Resveratrol regulates the PTEN/AKT pathway through androgen receptor-dependent and -independent mechanisms in prostate cancer cell lines.

Wang Y, Romigh T, He X, Orloff MS, Silverman RH, Heston WD, Eng C. Wang Y, et al. Hum Mol Genet. 2010 Nov 15;19(22):4319-29. doi: 10.1093/hmg/ddq354. Epub 2010 Aug 20. Hum Mol Genet. 2010. PMID: 20729295 Free PMC article.

3

Naturally occurring germline and tumor-associated mutations within the ATP-binding motifs of PTEN lead to oxidative damage of DNA associated with decreased nuclear p53.

He X, Ni Y, Wang Y, Romigh T, Eng C. He X, et al. Among authors: wang y. Hum Mol Genet. 2011 Jan 1;20(1):80-9. doi: 10.1093/hmg/ddq434. Epub 2010 Oct 6. Hum Mol Genet. 2011. PMID: 20926450 Free PMC article.

4

Resveratrol enhances the anti-tumor activity of the mTOR inhibitor rapamycin in multiple breast cancer cell lines mainly by suppressing rapamycin-induced AKT signaling.

He X, Wang Y, Zhu J, Orloff M, Eng C. He X, et al. Among authors: wang y. Cancer Lett. 2011 Feb 28;301(2):168-76. doi: 10.1016/j.canlet.2010.11.012. Epub 2010 Dec 17. Cancer Lett. 2011. PMID: 21168265

5

PTEN lipid phosphatase activity and proper subcellular localization are necessary and sufficient for down-regulating AKT phosphorylation in the nucleus in Cowden syndrome.

He X, Saji M, Radhakrishnan D, Romigh T, Ngeow J, Yu Q, Wang Y, Ringel MD, Eng C. He X, et al. Among authors: wang y. J Clin Endocrinol Metab. 2012 Nov;97(11):E2179-87. doi: 10.1210/jc.2012-1991. Epub 2012 Sep 7. J Clin Endocrinol Metab. 2012. PMID: 22962422 Free PMC article.

6

Transcription factor KLLN inhibits tumor growth by AR suppression, induces apoptosis by TP53/TP73 stimulation in prostate carcinomas, and correlates with cellular differentiation.

Wang Y, Radhakrishnan D, He X, Peehl DM, Eng C. Wang Y, et al. J Clin Endocrinol Metab. 2013 Mar;98(3):E586-94. doi: 10.1210/jc.2012-3490. Epub 2013 Feb 5. J Clin Endocrinol Metab. 2013. PMID: 23386643 Free PMC article.

7

Androgen receptor-induced tumor suppressor, KLLN, inhibits breast cancer growth and transcriptionally activates p53/p73-mediated apoptosis in breast carcinomas.

Wang Y, He X, Yu Q, Eng C. Wang Y, et al. Hum Mol Genet. 2013 Jun 1;22(11):2263-72. doi: 10.1093/hmg/ddt077. Epub 2013 Feb 14. Hum Mol Genet. 2013. PMID: 23418309

8

Activation of AR sensitizes breast carcinomas to NVP-BEZ235's therapeutic effect mediated by PTEN and KLLN upregulation.

Wang Y, Yu Q, He X, Romigh T, Altemus J, Eng C. Wang Y, et al. Mol Cancer Ther. 2014 Feb;13(2):517-27. doi: 10.1158/1535-7163.MCT-13-0655. Epub 2013 Dec 19. Mol Cancer Ther. 2014. PMID: 24356815

9

Cowden syndrome-related mutations in PTEN associate with enhanced proteasome activity.

He X, Arrotta N, Radhakrishnan D, Wang Y, Romigh T, Eng C. He X, et al. Among authors: wang y. Cancer Res. 2013 May 15;73(10):3029-40. doi: 10.1158/0008-5472.CAN-12-3811. Epub 2013 Mar 8. Cancer Res. 2013. PMID: 23475934 Free PMC article.

10

Nuclear KLLN expression associates with improved relapse-free survival for prostate carcinoma.

Wang Y, Roma A, Nolley R, Abdul-Karim F, Peehl DM, Eng C. Wang Y, et al. Endocr Relat Cancer. 2014 Aug;21(4):579-86. doi: 10.1530/ERC-14-0148. Endocr Relat Cancer. 2014. PMID: 24972837

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

293,023 results

Search Page

Filters